Partner Article
Salford-based BioClinics gets green light to expand testing
Salford testing firm BioClinics is set for further growth after securing approval to supply its services to several key target markets.
BioClinics conducts its tests by collecting and analysing urine and breath samples. It operates a network of clinics and mobile sample collectors across the UK and Ireland.
The firm has gained accreditations from Achilles Group, which evaluates suppliers on behalf of companies and organisations operating in nearly a dozen sectors.
BioClinics has passed industry audits for its workplace drug and alcohol tests in the transport, rail and utilities sectors.
The accreditations mean BioClinics is now an approved supplier of pre-employment and random tests to the rail and transport sectors, including Network Rail and its sub-contractors, and to utility companies including National Grid and its sub-contractors.
BioClinics experiencing a 470% rise in the number of annual tests it carried out between 2010 and 2013.
Nichola McChrystal, founder and scientific director of BioClinics, said: “We are aiming to double the number of tests we carry out over the next six months. In the longer term, major investment projects such as the HS2 and HS3 rail links should generate even greater demand for our testing services.”
This was posted in Bdaily's Members' News section by Sophia Taha .
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome
The rise of an alternative investor model